|
1
|
Jia J, Li J, Qu H, Li M, Zhang S, Hao J, Gao X, Meng X, Sun Y, Hakonarson H, Zeng X, Xia Q, Li J. New insights into hallux valgus by whole exome sequencing study. Exp Biol Med (Maywood) 2021; 246:1607-1616. [PMID: 33926255 PMCID: PMC8326439 DOI: 10.1177/15353702211008641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Accepted: 03/13/2021] [Indexed: 11/16/2022] Open
Abstract
The traditional view is that the occurrence and development of hallux valgus (HV) are mainly due to environmental factors. Recent studies have suggested the large contribution of genetic heritability to HV, but it remains elusive about the genetic variants underlying the development of HV. To gain knowledge about the molecular mechanisms of HV pathogenesis by genetic approach, whole exome sequencing studies were performed in 10 individuals (7 affected by HV and 3 unaffected) from three independent families. Specific mutations were found to be related to the pathogenesis of HV and conform to the laws of inheritance. A total of 36 genes with functional candidate single nucleotide variants were identified. Genetic predisposition plays an important role in the development of HV. Interestingly, some of these genes are related to chronic arthritis, such as the complement encoding gene C7, or are related to long toe or long fingers, such as TTN, COL6A3, LARS, FIG4, and CBS. This study identified rare potentially pathogenic mutations represented by genes related to digital anomalies and chronic arthritis underlying the familial types of HV, which acquired new insights into the genetic and physiological foundations of HV, thereby might improve accurate prevention and drug development for HV.
Collapse
Affiliation(s)
- Jun Jia
- Department of Surgery of Foot and Ankle, Tianjin Hospital,
Tianjin 300211, China
| | - Junyi Li
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Huiqi Qu
- Center for Applied Genomics, Children’s Hospital of
Philadelphia, Philadelphia, PA 19104-4399, USA
| | - Mengyu Li
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Sipeng Zhang
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Jun Hao
- Tianjin University of Traditional Chinese Medicine, Tianjin
301617, China
| | - Xinyi Gao
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Xinyi Meng
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Yan Sun
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Hakon Hakonarson
- Center for Applied Genomics, Children’s Hospital of
Philadelphia, Philadelphia, PA 19104-4399, USA
- Division of Human Genetics, Children’s Hospital of Philadelphia,
Philadelphia, PA 19104-4399, USA
- Department of Pediatrics, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, PA 19104-6243, USA
| | - Xiantie Zeng
- Department of Surgery of Foot and Ankle, Tianjin Hospital,
Tianjin 300211, China
| | - Qianghua Xia
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| | - Jin Li
- Department of Cell Biology, the Province and Ministry
Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of
Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China
| |
Collapse
|
|
2
|
Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KMJ, Kitas GD. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 2011; 17:47-58. [PMID: 20390282 DOI: 10.2174/138161211795049804] [Citation(s) in RCA: 774] [Impact Index Per Article: 59.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2010] [Accepted: 01/17/2011] [Indexed: 01/12/2023]
Abstract
Patients with rheumatoid arthritis (RA) are at high risk of cardiovascular events. Platelet biomarkers are involved in inflammation, atherosclerosis and thrombosis. Cardiovascular and RA-associated factors can alter the structure and function of platelets, starting from megakaryocytopoiesis. Reactive megakaryocytopoiesis increases circulating platelets count and triggers hyperactivity. Hyperactive platelets target synovial membranes with subsequent local rheumatoid inflammation. Hyperactive platelets interact with other cells, and target the vascular wall. Accumulating evidence suggests that disease modifying anti-rheumatic drugs (DMARD) decrease platelet activity.
Collapse
Affiliation(s)
- Armen Yuri Gasparyan
- Department of Rheumatology, Clinical Research Unit, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust (Teaching), Dudley DY1 2HQ, West Midlands, UK.
| | | | | | | | | |
Collapse
|
|
3
|
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 2011; 31:153-64. [PMID: 20390282 DOI: 10.1007/s00296-010-1446-x] [Citation(s) in RCA: 97] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2009] [Accepted: 03/12/2010] [Indexed: 12/20/2022]
Abstract
Patients with rheumatoid arthritis (RA) are at high risk of cardiovascular events. Platelet biomarkers are involved in inflammation, atherosclerosis and thrombosis. Cardiovascular and RA-associated factors can alter the structure and function of platelets, starting from megakaryocytopoiesis. Reactive megakaryocytopoiesis increases circulating platelets count and triggers hyperactivity. Hyperactive platelets target synovial membranes with subsequent local rheumatoid inflammation. Hyperactive platelets interact with other cells, and target the vascular wall. Accumulating evidence suggests that disease modifying anti-rheumatic drugs (DMARD) decrease platelet activity.
Collapse
|